Your browser doesn't support javascript.
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.
Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al-Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Anderson, Laura; Chauhan, Saleena Rani; Maddams, Rebecca; Soutar, Richard; Triantafillou, Margarita; Prideaux, Steve; Obeidalla, Abubaker; Eyre, Toby A; Bygrave, Ceri; Kothari, Jaimal; Basu, Supratik; Ramasamy, Karthik.
  • Djebbari F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Rampotas A; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Vallance G; Oxford University Clinical Academic Graduate School, Oxford, UK.
  • Panitsas F; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Basker N; Department of Haematology, Laiko General Hospital, Athens, Greece.
  • Sangha G; University Hospital Southampton, Southampton, UK.
  • Salhan B; Milton Keynes Hospital, Milton Keynes, UK.
  • Karim F; Birmingham Heartlands Hospital, Birmingham, UK.
  • Al-Kaisi F; Good Hope Hospital, Birmingham, UK.
  • Gudger A; Solihull Hospital, Birmingham, UK.
  • Ngu L; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Poynton M; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Lam HPJ; The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Morgan L; Royal Derby Hospital, Derby, UK.
  • Yang L; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Young J; Queen Elizabeth Hospital, Birmingham, UK.
  • Walker M; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Tsagkaraki I; Royal Berkshire Hospital, Reading, UK.
  • Anderson L; Guy's and St Thomas NHS Foundation Trust, London, UK.
  • Chauhan SR; University Hospital of UK, London, UK.
  • Maddams R; University Hospitals Sussex NHS Foundation Trust, Chichester, UK.
  • Soutar R; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Triantafillou M; University Hospital Crosshouse, Crosshouse, UK.
  • Prideaux S; Stoke Mandeville Hospital, Aylesbury, UK.
  • Obeidalla A; Royal United Hospital Bath, Bath, UK.
  • Eyre TA; West Midlands Research Consortium (WMRC), West Midlands, UK.
  • Bygrave C; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Kothari J; Poole Hospital, Poole, UK.
  • Basu S; Beatson Oncology Centre, Glasgow, UK.
  • Ramasamy K; Manchester Royal Infirmary, Manchester, UK.
Br J Haematol ; 201(1): 162-167, 2023 04.
Article in English | MEDLINE | ID: covidwho-2294332
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Frailty / Multiple Myeloma Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Br J Haematol Year: 2023 Document Type: Article Affiliation country: Bjh.18672

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Frailty / Multiple Myeloma Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Br J Haematol Year: 2023 Document Type: Article Affiliation country: Bjh.18672